Finally, the clinical relevance of these findings is underscored in CRC patients with tumors displaying ACSL1/ACSL4/SCD simultaneous overexpression that show an increased risk of relapse compared to other patients within the same clinicopathological stage. The gene discussed is SCD; the disease is colorectal carcinoma.